Table 2 Association of miR-372 expression in human glioma tissues with different clinicopathological features
From: Correlation of microrna-372 upregulation with poor prognosis in human glioma
Clinicopathological features | No. of cases | miR-372 expression | P | |
|---|---|---|---|---|
High (n, %) | Low (n, %) | |||
WHO grade | ||||
I | 18 | 2 (11.1) | 16 (88.9) | 0.008 |
II | 14 | 2 (14.3) | 12 (85.7) | |
III | 38 | 24 (63.2) | 14 (36.8) | |
IV | 58 | 50 (86.2) | 8 (13.8) | |
Age | ||||
<55 | 52 | 33 (63.5) | 19 (36.5) | NS |
≥55 | 76 | 45 (59.2) | 31 (40.8) | |
Gender | ||||
Male | 76 | 45 (59.2) | 31 (40.8) | NS |
Female | 52 | 33 (63.5) | 19 (36.5) | |
KPS | ||||
<80 | 78 | 56 (71.8) | 22 (28.2) | 0.01 |
≥80 | 50 | 22 (44.0) | 28 (56.0) | |